Evoke Wealth’s GoodRx Holdings GDRX Stock Holding History

Evoke Wealth’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-265	Closed	-$1K	–	676
2022 Q3	$1K	Hold	265	–	–	﹤0.01%	1111
2022 Q2	$2K	Sell	265 -128	-33%	-$1.43K	﹤0.01%	1042
2022 Q1	$8K	Hold	393	–	–	﹤0.01%	807
2021 Q4	$13K	Buy	393 +128	+48%	+$5.15K	﹤0.01%	745
2021 Q3	$10K	Hold	265	–	–	﹤0.01%	743
2021 Q2	$10K	Hold	265	–	–	﹤0.01%	751
2021 Q1	$10K	Hold	265	–	–	﹤0.01%	692
2020 Q4	$11K	Hold	265	–	–	﹤0.01%	572
2020 Q3	$15K	Buy	+265	New	+$14K	﹤0.01%	510

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Evoke Wealth's GDRX Position: Q4 2022 in Review

Evoke Wealth sold out of GoodRx Holdings (GDRX) in Q4 2022, closing a stake of 265 shares — an estimated $1K sold.

Evoke Wealth first reported a position in GDRX in Q3 2020 and held it in 9 quarters. The position peaked at $15K in Q3 2020. 160 funds tracked by Wall St. Rank hold GDRX as of Q4 2022.

Evoke Wealth reported no remaining GoodRx Holdings position as of Q4 2022 after selling out during the quarter.
Evoke Wealth sold 265 GoodRx Holdings shares in Q4 2022, an estimated $1K.
Evoke Wealth first reported a position in GoodRx Holdings in Q3 2020 and held it in 9 quarters.
Evoke Wealth's GoodRx Holdings position peaked at $15K in Q3 2020.
160 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.